Company: NCEL
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065783
Chunk: 800

Company: NewcelX Ltd.
Filing Date: 2025-07-18
Form: F-4/A
Chunk 800
---
 |            1,273 |   |     |   1,273 |    |
| Reserve from share-based payment transactions           |     |   19 |     |              452 |   |     |     518 |    |
| Reserve from transactions with controlling shareholders |     |      |     |            4,105 |   |     |   3,830 |    |
| Foreign currency translation reserve                    |     |      |     |           (1,094 | ) |     |  (1,002 | )  |
| Accumulated deficit                                     |     |      |     |          (76,530 | ) |     | (69,345 | )  |
| Total equity                                            |     |      |     |           (7,996 | ) |     |  (1,202 | )  |
|                                                         |     |      |     |              903 |   |     |   2,307 |    |

____________ *Less than United States Dollars (“USD”) $1 thousand. **Reclassification see Note 2H.

| June 5, 2025            |     | /s/ Ronen Twito   |     | /s/ Liora Oren |     | /s/ Uri Ben Or |
|:------------------------|:----|:------------------|:----|:---------------|:----|:---------------|
| Date of approval of the 
 financial statements    |     | Ronen Twito       
 CEO and Executive 
 Chairman of BOD   |     | Liora Oren     
 Director       |     | Uri Ben Or     
 CFO            |

The accompanying Notes are an integral part of the financial statements.

Annex G-3

KADIMASTEM LTD.
Statements of Profit or Loss and Other Comprehensive Loss

|                                                                                                                             |     | Note |     |                  Year ended December 31, 
                                     2024 |   |     |  2023 |   |     |  2022 |   |
|:----------------------------------------------------------------------------------------------------------------------------|:----|-----:|:----|-----------------------------------------:|:--|:----|------:|:--|:----|------:|:--|
|                                                                                                                             |     |      |     | USD in thousands (except per share data) |   |     |       |   |     |       |   |
| Research and development expenses                                                                                           |     |  20a |     |                                      992 |   |     |